CareLit · DOI-Nachweis · Pneumologie
Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program
DOI 10.1055/s-0039-1678313
Bibliografische Angaben
Nachweis in CareLit
Autor:innenH Ortega, E Meyer, G Brusselle, K Asano, RG Price, C Prazma, F Albers, S Yancey, G Gleich
ZeitschriftPneumologie
AusgabeS 01 S 01/2019
Jahrgang / SeitenJg. 73
Kernaussage aus der Literatur
Abstract-Vorschau
Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program
Zitieren
Zitierempfehlung
H Ortega, E Meyer, G Brusselle, K Asano, RG Price, C Prazma, F Albers, S Yancey, G Gleich (2019) Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program. Pneumologie, 73 (S 01 S 01). https://doi.org/10.1055/s-0039-1678313
Mit CareLit weiterarbeiten